Treatment Landscape for Patients with Castration-Resistant Prostate Cancer: Patient Selection and Unmet Clinical Needs

Metastatic castration resistant prostate cancer (CRPC) is an inevitably fatal disease. However, in recent years, several treatments have been shown to improve the outcome of CRPC patients both in the non-metastatic (nmCRPC) as well as the metastatic setting (mCRPC). In nmCRPC patients with a PSA dou...

Descripción completa

Detalles Bibliográficos
Autores principales: Turco, Fabio, Gillessen, Silke, Cathomas, Richard, Buttigliero, Consuelo, Vogl, Ursula Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529226/
https://www.ncbi.nlm.nih.gov/pubmed/36199275
http://dx.doi.org/10.2147/RRU.S360444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529226/
https://www.ncbi.nlm.nih.gov/pubmed/36199275
http://dx.doi.org/10.2147/RRU.S360444

Ejemplares similares